Home > Boards > US Listed > Medical - Drugs >

Replimune (REPL)

REPL RSS Feed
Add REPL Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 4/3/2022 7:15:15 PM - Followers: 4 - Board type: Free - Posts Today: 0

REPL
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
REPL News: SVB Securities Thinks Replimune Group’s Stock is Going to Recover 05/20/2022 04:45:58 AM
REPL News: Replimune Reports Fiscal Fourth Quarter and Year-Ended 2022 Financial Results and Provides Corporate Update 05/19/2022 04:00:00 AM
REPL News: Statement of Changes in Beneficial Ownership (4) 05/18/2022 03:05:03 PM
REPL News: Statement of Changes in Beneficial Ownership (4) 05/18/2022 03:04:18 PM
REPL News: Statement of Changes in Beneficial Ownership (4) 05/18/2022 03:03:48 PM
PostSubject
#68   PR https://www.biospace.com/article/releases/replimune-provides-new-clinical-dat jondoeuk 04/03/22 07:15:15 PM
#67   Link to webcast https://wsw.com/webcast/cc/repl2/1432638 jondoeuk 03/21/22 05:47:11 PM
#66   Members of its executive team and KOLs will jondoeuk 03/21/22 05:46:25 PM
#65   The password is: GETICA_220126 https://vimeo.com/674771361 jondoeuk 02/17/22 10:29:47 PM
#64   The company will host an investor event in jondoeuk 02/05/22 07:57:13 PM
#63   SITC posters https://ir.replimune.com/static-files/fb937395-5281-41c1-8dba-aca83 jondoeuk 11/12/21 11:53:33 AM
#62   nice analysis. jondoeuk 11/08/21 07:00:41 PM
#61   nice analysis. Yeah most are Trial in puravida 10/15/21 09:25:42 AM
#60   Looking forward to seeing these updates from SITC. jondoeuk 10/05/21 09:03:30 PM
#59   Looking forward to seeing these updates from SITC. puravida 10/02/21 04:21:29 AM
#58   SITC: Abstract Title: A phase 1 clinical trial of jondoeuk 10/01/21 12:21:13 PM
#57   Link https://wsw.com/webcast/blair59/panel4/2160224 jondoeuk 07/13/21 05:50:30 PM
#56   Dr. Coffin, will participate in a panel titled jondoeuk 07/11/21 01:20:14 PM
#55   The PR https://www.globenewswire.com/news-release/2021/06/03/2241138/0/en/Replim jondoeuk 06/03/21 11:49:20 AM
#54   Link to the webcast https://wsw.com/webcast/cc/repl/1379538 jondoeuk 04/28/21 08:51:27 PM
#53   The company will host an investor event to jondoeuk 04/28/21 08:49:43 PM
#52   The posters https://ir.replimune.com/static-files/8ceb7c8e-cf10-4f65-b6ff-30f2aa jondoeuk 04/10/21 03:41:51 PM
#51   Dr. Coffin has said that additional data from jondoeuk 03/18/21 06:21:35 PM
#50   Thanks J I expect to see something significant very soon elcheepo 03/12/21 07:09:53 PM
#49   Why the steep drop today? jondoeuk 03/12/21 07:07:02 PM
#48   AACR https://www.abstractsonline.com/pp8/#!/9325/presentation/4664 https://www.a jondoeuk 03/10/21 06:02:28 PM
#47   Why the steep drop today? If this continues, elcheepo 03/08/21 07:07:45 PM
#46   Yes, this year; jondoeuk 03/08/21 06:25:42 PM
#45   So is there anything of interest coming in elcheepo 03/08/21 06:14:59 PM
#44   JP Morgan webcast https://jpmorgan.metameetings.net/events/healthcare21/sessions jondoeuk 01/20/21 10:22:17 PM
#43   SITC posters: jondoeuk 11/10/20 04:29:52 PM
#42   Updated corporate presentation (RP1 & RP2 data) https://ir.replimune.com/static- jondoeuk 10/22/20 02:11:53 PM
#41   SITC Title: (650) An Open-label, multicenter, Phase 1/2 clinical jondoeuk 10/14/20 01:16:51 PM
#40   Slides from the IO Summit (the company isn't jondoeuk 10/07/20 06:41:37 PM
#39   Slides from the event https://ir.replimune.com/static-files/def39b44-9f58-4fbd-8a36-2f96f628519a jondoeuk 06/24/20 05:45:38 PM
#38   The company will host a conference call to jondoeuk 06/01/20 01:14:21 PM
#37   Looks good https://meetinglibrary.asco.org/record/192615/abstract jondoeuk 05/15/20 09:13:09 PM
#36   Initial data on RP2 could be presented at SITC. jondoeuk 05/02/20 06:55:20 PM
#35   Two new trials listed. The first is a jondoeuk 05/02/20 02:28:22 PM
#34   Small number, but encouraging data on another 'armed' jondoeuk 04/22/20 09:09:19 PM
#33   An update from last month https://ir.replimune.com/static-files/7aa0f042-b0cf-4f jondoeuk 02/19/20 07:10:25 PM
#32   J.P. Morgan webcast https://jpmorgan.metameetings.net/events/hc20/sessions/29931 jondoeuk 01/26/20 03:09:48 PM
#31   The company has appointed Jean M. Franchi as jondoeuk 12/09/19 04:06:52 PM
#30   Piper Jaffray slides https://ir.replimune.com/static-files/023a7710-3ec0-4f57-a7 jondoeuk 12/08/19 01:33:12 PM
#29   So the company will raise ~$80M with this jondoeuk 11/16/19 12:49:24 PM
#28   The PR https://markets.businessinsider.com/news/stocks/replimune-presents-initia jondoeuk 11/08/19 11:34:44 AM
#27   The company will host an investor event to jondoeuk 11/03/19 03:23:18 PM
#26   Finally the RP2 trial starts! jondoeuk 10/24/19 04:49:43 PM
#25   I did not expect this data [1,2]. It's jondoeuk 10/15/19 11:57:20 AM
#24   SITC title (P433) Initial results of the phase jondoeuk 10/01/19 06:24:15 PM
#23   It is finally recruiting. Clock starts now. jondoeuk 09/15/19 07:22:11 PM
#22   An update (of sorts) on the company's manufacturing jondoeuk 08/31/19 02:13:06 PM
#21   A new preclinical paper https://jitc.biomedcentral.com/articles/10.1186/s40425-0 jondoeuk 08/12/19 11:51:47 AM
#20   The randomised trial has been added https://clinicaltrials.gov/ct2/show/NCT04050 jondoeuk 08/08/19 03:24:39 PM
#19   I've searched for titles at the ESMO website jondoeuk 08/06/19 04:42:55 PM
PostSubject
Consent Preferences